Literature DB >> 29771810

Transanal Total Mesorectal Excision vs Laparoscopic Total Mesorectal Excision in the Treatment of Low and Middle Rectal Cancer: A Propensity Score Matching Analysis.

Roberto Persiani1, Alberto Biondi, Francesco Pennestrì, Valeria Fico, Veronica De Simone, Flavio Tirelli, Francesco Santullo, Domenico D'Ugo.   

Abstract

BACKGROUND: Transanal total mesorectal excision is a novel and promising technique in the treatment of low and middle rectal cancer.
OBJECTIVE: This study aimed to compare the safety and feasibility of transanal total mesorectal excision versus laparoscopic total mesorectal excision.
DESIGN: This was a retrospective study using propensity score matching analysis. SETTINGS: This study was conducted in a single high-volume university hospital. PATIENTS: Patients with low and middle rectal cancer who underwent total mesorectal excision with curative intent between 2007 and 2017 were recruited.
INTERVENTIONS: Laparoscopic total mesorectal excision and transanal total mesorectal excision had been performed. MAIN OUTCOME MEASURES: Intraoperative, pathological, and 30-day postoperative outcomes were compared between the transanal and laparoscopic groups.
RESULTS: Overall, 105 patients were selected from the whole sample of 316 patients with rectal cancer. After propensity score matching analysis, 46 patients for each group were compared. Laparoscopic total mesorectal excision was associated with a higher conversion rate to open surgery (19.6% vs 0%, p = 0.002). Transanal total mesorectal excision showed a longer distal resection margin (15 mm vs 25 mm; p < 0.001), and similar results regarding the completeness of mesorectal excision and circumferential resection margin involvement, compared to laparoscopy. There were no statistically significant differences between the 2 groups in terms of postoperative complications. LIMITATIONS: The study was limited by its retrospective design and the small size of the sample.
CONCLUSIONS: Transanal total mesorectal excision is a safe and feasible technique that results in a high-quality rectal cancer resection specimen and favorable 30-day postoperative outcomes.

Entities:  

Mesh:

Year:  2018        PMID: 29771810     DOI: 10.1097/DCR.0000000000001063

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  16 in total

1.  [Transanal total mesorectal excision : A useful complementary method for minimally invasive surgery of rectal cancer].

Authors:  A D Rink; F Aigner; M Biebl; A Fürst; W Kneist
Journal:  Chirurg       Date:  2019-06       Impact factor: 0.955

2.  Technical variations and feasibility of transanal ileal pouch-anal anastomosis for ulcerative colitis and inflammatory bowel disease unclassified across continents.

Authors:  K Zaghiyan; J Warusavitarne; A Spinelli; P Chandrasinghe; F Di Candido; P Fleshner
Journal:  Tech Coloproctol       Date:  2018-12-11       Impact factor: 3.781

3.  Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer.

Authors:  Shahin Hajibandeh; Shahab Hajibandeh; Mokhtar Eltair; Anil T George; Vijay Thumbe; Andrew W Torrance; Misra Budhoo; Howard Joy; Rajeev Peravali
Journal:  Int J Colorectal Dis       Date:  2020-03-02       Impact factor: 2.571

4.  Transanal total mesorectal excision in the prone jackknife position without being conscious of the size of prostatic enlargement for lower rectal cancer.

Authors:  Dai Uematsu; Gaku Akiyama; Takeiko Sugihara; Akiko Magishi; Minoru Imai; Kojiro Ono
Journal:  Int Cancer Conf J       Date:  2020-04-20

5.  Comparison of Short-Term Clinical and Pathological Outcomes after Transanal versus Laparoscopic Total Mesorectal Excision for Low Anterior Rectal Resection Due to Rectal Cancer: A Systematic Review with Meta-Analysis.

Authors:  Mateusz Rubinkiewicz; Agata Czerwińska; Piotr Zarzycki; Piotr Małczak; Michał Nowakowski; Piotr Major; Andrzej Budzyński; Michał Pędziwiatr
Journal:  J Clin Med       Date:  2018-11-19       Impact factor: 4.241

6.  Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer: a meta-analysis of short-term outcomes.

Authors:  Dezheng Lin; Zhaoliang Yu; Wenpei Chen; Jiancong Hu; Xuming Huang; Zhen He; Yi-Feng Zou; Xiangan Yu; Xuefeng Guo; Xiao-Jian Wu
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-02-08       Impact factor: 1.195

7.  Transanal total mesorectal excision: how are we doing so far?

Authors:  C L Sparreboom; N Komen; D Rizopoulos; H L van Westreenen; P G Doornebosch; J W T Dekker; A G Menon; J B Tuynman; F Daams; D Lips; W M U van Grevenstein; T M Karsten; J F Lange; A D'Hoore; A M Wolthuis
Journal:  Colorectal Dis       Date:  2019-03-26       Impact factor: 3.788

8.  Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.

Authors:  Sapho Xenia Roodbeen; Marta Penna; Hugh Mackenzie; Miranda Kusters; Andrew Slater; Oliver M Jones; Ian Lindsey; Richard J Guy; Chris Cunningham; Roel Hompes
Journal:  Surg Endosc       Date:  2018-10-22       Impact factor: 4.584

9.  Evaluation of the learning curve of transanal total mesorectal excision: single-centre experience.

Authors:  Mateusz Rubinkiewicz; Katarzyna Truszkiewicz; Michał Wysocki; Jan Witowski; Grzegorz Torbicz; Michal M Nowakowski; Andrzej Budzynski; Michał Pędziwiatr
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-02-05       Impact factor: 1.195

Review 10.  Role of minimally invasive surgery for rectal cancer.

Authors:  Kurt A Melstrom; Andreas M Kaiser
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.